TheProductLawyers.com announces the finalized dates for bellwether trials in the mass litigation against Xarelto and its manufacturers—Bayer AG and Janssen Pharmaceuticals, a division of Johnson & Johnson Corporation.
FDA & Prescription Drugs
TheProductLawyers.com reports on the lawsuit filed by an Ohio husband and wife against Xarelto and its manufacturers—Janssen Pharmaceuticals and Bayer AG.
TheProductLawyers.com examines the combination of more than 2,000 lawsuits against Xarelto and its manufacturers—Janssen Pharmaceuticals and Bayer AG.
TheProductLawyers.com announces new evidence disclosed in a recent article for Business Insider (BI). Bayer AG and the Johnson & Johnson subsidiary company, Janssen Pharmaceuticals, have lately been the subject of mounting litigation alleging a heightened risk of bleeding associated with their drug, Xarelto.
TheProductLawyers.com reports on the surging controversy surrounding Duke University Clinical Trials for Xarelto, a new-generation blood-thinning drug manufactured by Janssen Pharmaceuticals, a Johnson and Johnson Corporation subsidiary, and Bayer AG.
In October of 2015, a new lawsuit was filed that veered from these standard accusations and focused instead on the ineffectiveness of the daily dosage requirement of Xarelto that did not take into account a patient's size or weight.
A woman claims, that upon taking the type II diabetes drug, Invokana, she developed diabetic ketoacidosis. The complaint states that she began taking the drug in December of 2014 and developed ketoacidosis a short time after this.
This newest wrongful death lawsuit centers on allegations of false claims made by the manufacturers of the drug and was filed on November 20, 2015.
TheProductLawyers.com reports on the scheduling of the first 4 bellwether Xarelto lawsuit cases that have been selected by Presiding Judge Eldon Fallon of the Eastern District of Louisiana who is the administrator of the current Multidistrict Litigation (MDL), identified as number 2592.
- Home & Family